Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Consolidated Net Profit

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Consolidated Net Profit ₹39 Cr₹40 Cr₹35 Cr₹-67 Cr₹12 Cr

What is the latest Consolidated Net Profit of NATH BIOGENES (INDIA) ?

The latest Consolidated Net Profit ratio of NATH BIOGENES (INDIA) is ₹39 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹39 Cr
Mar2024₹40 Cr
Mar2023₹35 Cr
Mar2022₹-67 Cr
Mar2013₹12 Cr

How is Consolidated Net Profit of NATH BIOGENES (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹39 Cr
-2.57
Mar2024 ₹40 Cr
13.11
Mar2023 ₹35 Cr
Positive
Mar2022 ₹-67 Cr
Negative
Mar2013 ₹12 Cr -

Compare Consolidated Net Profit of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹278.7 Cr -3.5% -5.1% -14.1% Stock Analytics
KAVERI SEED COMPANY ₹3,592.5 Cr -4.2% -10.4% -37.7% Stock Analytics
VENKYS (INDIA) ₹2,410.5 Cr 0.2% 12% 22.3% Stock Analytics
AVT NATURAL PRODUCTS ₹1,314.1 Cr -3.7% 6% 16.4% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹903.5 Cr -5.4% -6.4% NA Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹509.8 Cr -0.3% 6.9% 1% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-3.5%

-5.1%

-14.1%

SENSEX

-2.8%

-5.2%

-8.4%


You may also like the below Video Courses